SPDR S&P Biotech ETF Newsroom

AbbVie Says Canada's Drug Agency Has Issued Its First-Ever Time-limited Reimbursement Recommendation For EPKINLY (Epcoritamab)

Benzinga07:05 ET

Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today

Benzinga17:30 ET

Cerevel Therapeutics Gains as Investors Appear More Confident on FTC Approval for AbbVie

Seeking Alpha16:03 ET

$100 Invested In This Stock 15 Years Ago Would Be Worth $5,100 Today

Benzinga15:00 ET

AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst

Benzinga14:53 ET

Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst

Benzinga13:04 ET

A Glimpse Into The Expert Outlook On Biomarin Pharmaceutical Through 10 Analysts

Benzinga13:00 ET

Breaking Down Gilead Sciences: 10 Analysts Share Their Views

Benzinga12:00 ET

Regeneron Pharmaceuticals Analyst Ratings

BenzingaJul 22 11:31 ET · Ratings

Gilead Sciences Analyst Ratings

BenzingaJul 22 11:25 ET · Ratings

Biomarin Pharmaceutical Analyst Ratings

BenzingaJul 22 11:21 ET · Ratings

Alnylam Pharmaceuticals Analyst Ratings

BenzingaJul 22 11:18 ET · Ratings

Kamala Harris' Potential Impact on Health Care Stocks

Seeking AlphaJul 21 21:02 ET

Here Are Big Pharma's Leading Blockbuster Makers

Seeking AlphaJul 21 07:00 ET

What to Expect in the Week Ahead (Google and Tesla Earnings; GDP and PCE Data)

Moomoo Breakfast USJul 21 05:36 ET

Financials Dominate in Q2 as Wall Street Slides Amidst Concerns on Tech - Earnings Scorecard

Seeking AlphaJul 20 15:58 ET

Catalyst Watch: Earnings Deluge, Farnborough Airshow, Paris Olympics, and Trump Talks Crypto

Seeking AlphaJul 19 15:00 ET

Check Out What Whales Are Doing With GILD

BenzingaJul 19 14:48 ET

Peeling Back The Layers: Exploring AbbVie Through Analyst Insights

BenzingaJul 19 13:00 ET

Peering Into Regeneron Pharmaceuticals's Recent Short Interest

BenzingaJul 19 12:00 ET